Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02651662
Title Study of REGN2810 and REGN1979 in Patients With Lymphoma
Acronym CLIO-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | ESP | DEU

No variant requirements are available.